Recon: FDA authorizes boosters for at-risk and older Americans; Novavax applies for WHO emergency listing
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy